GLOBUS MEDICAL INC GMED
$85.90
-0.05%
at last close
Analyst Consensus
- Consensus Rating
- Buy (10 Buy · 3 Hold · 0 Sell)
- Average Price Target
- $100.00
- Implied Upside
- +16.4%
- Price Target Range
- $80.00 – $123.00
- Analysts (12 mo)
- 13
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-07 | Wells FargoLarry Biegelsen |
Maintains | Overweight | $103 → $99 |
| 2026-07-28 | UBSMatthew Taylor |
Initiates coverage on | Neutral | $82 |
| 2026-07-16 | Truist SecuritiesRichard Newitter |
Maintains | Buy | $115 → $100 |
| 2026-07-13 | RBC CapitalShagun Singh |
Maintains | Outperform | $120 → $115 |
| 2026-07-09 | BMO Capital |
Initiates coverage on | Outperform | $94 |
| 2026-07-08 | StifelTom Stephan |
Maintains | Hold | $95 → $80 |
| 2026-06-15 | Piper SandlerMatt O'Brien |
Maintains | Overweight | $115 → $100 |
| 2026-05-08 | RBC CapitalShagun Singh |
Maintains | Outperform | $115 → $120 |
| 2026-05-08 | Wells FargoLarry Biegelsen |
Maintains | Overweight | $104 → $103 |
| 2026-05-08 | NeedhamDavid Saxon |
Maintains | Buy | $114 → $117 |
| 2026-02-26 | Wells FargoVik Chopra |
Maintains | Overweight | $98 → $104 |
| 2026-02-25 | BarclaysMatt Miksic |
Maintains | Overweight | $118 → $123 |
| 2026-02-25 | NeedhamDavid Saxon |
Maintains | Buy | $112 → $114 |
| 2026-01-30 | NeedhamDavid Saxon |
Upgrades | Hold → Buy | $112 |
| 2026-01-09 | Canaccord GenuityCaitlin Cronin |
Maintains | Buy | $105 → $112 |
| 2026-01-08 | Piper SandlerMatt O'Brien |
Reiterates | Overweight | $90 → $115 |
| 2025-12-17 | Canaccord GenuityCaitlin Cronin |
Maintains | Buy | $90 → $105 |
| 2025-12-17 | RBC CapitalShagun Singh |
Maintains | Outperform | $92 → $100 |
| 2025-12-17 | Freedom Capital MarketsKeith Hinton |
Initiates coverage on | Hold | $87 |
| 2025-12-02 | Morgan StanleyDrew Ranieri |
Maintains | Overweight | $70 → $100 |
| 2025-11-18 | Truist SecuritiesRichard Newitter |
Reiterates | Buy | $93 → $105 |
| 2025-11-10 | BarclaysMatt Miksic |
Maintains | Overweight | $106 → $114 |
| 2025-11-07 | RBC CapitalShagun Singh |
Maintains | Outperform | $88 → $92 |
| 2025-11-07 | Wells FargoVik Chopra |
Maintains | Overweight | $66 → $79 |
| 2025-11-07 | B of A SecuritiesCraig Bijou |
Upgrades | Neutral → Buy | $65 → $91 |
| 2025-11-07 | Truist SecuritiesRichard Newitter |
Upgrades | Hold → Buy | $65 → $93 |
| 2025-10-28 | StifelThomas Stephan |
Reinstates | Hold | $64 |
| 2025-08-08 | Wells FargoVik Chopra |
Maintains | Overweight | $76 → $66 |
| 2025-07-22 | Canaccord GenuityWilliam Plovanic |
Maintains | Buy | $97 → $90 |
| 2025-07-21 | NeedhamDavid Saxon |
Reiterates | Hold | — |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $85.90
- Market Cap
- $11.53 billion
- 52-Week Range
- $51.79 – $101.40
- Average Volume
- 1.65 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.